Increasing Optimal Use of HPV Vaccination in Primary Care

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-07

Study Completion Date

2024-04-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Washington University will evaluate the effectiveness of a multi-component implementation strategy to increase use of HPV vaccine in primary care practices.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination

NCT03442062

Human Papillomavirus Infection

COMPLETED NA

PREVENT Pilot HPV - Related Cancers Trial

NCT06738355

HPV Vaccination Uptake Vaccination Series Completion

COMPLETED NA

Intradermal, Fractional Dose of HPV Vaccines:

NCT04235257

HPV Infection HPV Vaccine

ACTIVE_NOT_RECRUITING PHASE4

PREVENT HPV -Related Cancers Trial

NCT07217145

HPV Vaccination Uptake Vaccination Series Completion

RECRUITING NA

A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates

NCT01526551

Human Papillomavirus

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators at Washington University will complete a cluster-randomized trial to evaluate the effectiveness of a multi-component implementation strategy (the intervention) to increase use of the HPV vaccine according to CDC guidelines. The unit of randomization is a community-based, primary care pediatric practice. Twenty practices will be randomized into two groups, the intervention group (n=10) or a wait-list control group (n=10). The intervention will be implemented over 2-years and includes: 1) an educational video for providers; 2) audit and feedback of vaccine coverage; 3) a communication strategy; and 4) practice facilitation.

The primary outcome of HPV vaccination by age 13 will be assessed at 24 months, and at 36 months to assess if change is sustained.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Papillomavirus Vaccines

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

Practices randomly assigned to this arm will receive the multi-component intervention.

Group Type EXPERIMENTAL

Practice Facilitation

Intervention Type OTHER

Practice facilitation to support quality improvement methods to effect practice change to develop a sustainable HPV vaccine delivery system.

Education

Intervention Type OTHER

An educational video to increase the provider's knowledge about guideline recommendations and patient and practice benefits of vaccination by age 13.

Audit and Feedback

Intervention Type OTHER

Audit and feedback of vaccine coverage to increase motivation to engage in practice change.

Communication Strategy

Intervention Type OTHER

A communication strategy to improve the provider's communication skills and their self-efficacy to address parental hesitation.

Wait list control group

Practices randomly assigned to this arm will be offered the intervention in the last two years of the study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Practice Facilitation

Practice facilitation to support quality improvement methods to effect practice change to develop a sustainable HPV vaccine delivery system.

Intervention Type OTHER

Education

An educational video to increase the provider's knowledge about guideline recommendations and patient and practice benefits of vaccination by age 13.

Intervention Type OTHER

Audit and Feedback

Audit and feedback of vaccine coverage to increase motivation to engage in practice change.

Intervention Type OTHER

Communication Strategy

A communication strategy to improve the provider's communication skills and their self-efficacy to address parental hesitation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Practices:

* Community-based pediatric primary care practices with 2 or more providers.
* Providers who deliver wellness care to preteens and adolescents.
* Willingness to participate in the practice facilitator-guided QI process.

Providers:

* Providers who deliver wellness care to preteens and adolescents.
* Willingness to complete study questionnaires.
* Willingness to participate in the practice facilitator-guided QI process.